Chargement en cours...
Tenapanor administration and the activity of the H(+)‐coupled transporter PepT1 in healthy volunteers
AIM: Tenapanor (RDX5791/AZD1722), an inhibitor of gastrointestinal Na(+)/H(+) exchanger NHE3, is being evaluated for the treatment of patients with constipation‐predominant irritable bowel syndrome and the treatment of hyperphosphataemia in patients with chronic kidney disease on dialysis. By reduci...
Enregistré dans:
| Publié dans: | Br J Clin Pharmacol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5582369/ https://ncbi.nlm.nih.gov/pubmed/28432691 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13313 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|